Pirillo, Angela

Global epidemiology of dyslipidaemias

Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D., & Catapano, A. L. (2021) · Nature Reviews Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 882

Apolipoprotein C-III: from pathophysiology to pharmacology

Norata, G. D., Tsimikas, S., Pirillo, A., & Catapano, A. L. (2015) · Trends in Pharmacological Sciences

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 182

Postprandial lipemia as a cardiometabolic risk factor

Pirillo, A., Norata, G. D., & Catapano, A. L. (2014) · Current Medical Research and Opinion

Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 108

The burden of hypercholesterolemia and ischemic heart disease in an ageing world

Pirillo, A., & Norata, G. D. (2023) · Pharmacological Research

Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk Factors

Cited by 75

Niemann-Pick C1-Like 1 (NPC1L1) inhibition and cardiovascular diseases

Pirillo, A., L. Catapano, A., & D. Norata, G. (2016) · Current Medicinal Chemistry

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 45

Fibrates : Do They Still Have a Role in Therapy in 2025?

Pirillo, A., Zambon, A., & Catapano, A. L. (2025) · Current Atherosclerosis Reports

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 4

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort

Arca, M., Calabrò, P., Solini, A., Pirillo, A., Gambacurta, R., Ray, K. K., & Catapano, A. L. (2026) · Nutrition, Metabolism and Cardiovascular Diseases

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3